Just weeks after Australia became the first country to approve the use of MDMA and psilocybin for treating mental health conditions, the decision has drawn.
Australia’s move to become the world’s first country to allow clinical prescribing of MDMA, and psilocybin for a spate of psychiatric conditions has left many clinicians and researchers concerned.
Decision to make the previously illicit drugs available is dogged by suggestions the decision was rushed. Decision to make the previously illicit drugs available is dogged by suggestions the decision was rushed.
Compared with other people with breast cancer, those with a preexisting severe mental illness were less likely to receive appropriate treatment and more likely to experience delays in receiving treatment, findings in Psycho-Oncology showed.